Helping Your Patients Navigate Tobramycin Supply Challenges

When a patient calls your office because their pharmacy can't fill their Tobramycin prescription, what do you do? In 2026, this scenario plays out more often than it should — and having a structured response ready can save your staff time, reduce patient anxiety, and prevent gaps in treatment.

This guide provides a practical, step-by-step approach for helping patients locate Tobramycin or transition to an appropriate alternative when supply is limited.

Current Availability Overview

Understanding which Tobramycin formulations are most affected helps you triage patient calls efficiently:

• Tobramycin ophthalmic (generic drops and ointment): Generally available. Spot shortages occur at individual pharmacy locations but rarely represent true market-wide shortages. Most patients can find stock within a few calls or by checking a nearby pharmacy.
• Tobramycin injection (IV/IM): Most shortage-prone. Intermittently on the ASHP shortage list. Primarily affects hospital and institutional settings, but outpatient infusion centers may also be impacted.
• Inhaled Tobramycin (TOBI, generics, TOBI Podhaler): Available through specialty pharmacies. Occasional disruptions, but multiple generic options have improved overall supply. TOBI Podhaler remains brand-only from Novartis.

Why Your Patients Can't Find Tobramycin

When patients report difficulty, the issue typically falls into one of these categories:

1. Pharmacy-level stock-out: The most common scenario. The specific pharmacy is out, but the drug is available elsewhere in the area.
2. Formulation-specific shortage: A particular vial size, manufacturer, or formulation is unavailable due to a manufacturing or distribution issue.
3. Specialty access barrier: For inhaled Tobramycin, the patient may need to use a specialty pharmacy rather than their retail pharmacy, which requires additional coordination.
4. Insurance/prior authorization delay: The medication is available, but insurance is blocking access pending clinical documentation — especially common with inhaled formulations.
5. Cost barrier: The patient found the medication but can't afford the copay or cash price, particularly for brand-name TOBI ($8,000+/cycle) or TOBI Podhaler ($8,000–$10,000+/cycle).

What Providers Can Do: 5 Practical Steps

Step 1: Direct Patients to Medfinder

Medfinder for Providers allows you to search for pharmacies near your patient that currently have Tobramycin in stock. You can:

• Search by formulation (ophthalmic, injection, inhalation)
• Filter by patient location
• Share results directly with patients or your front desk staff

This eliminates the "call every pharmacy" burden for your patients and your office.

Step 2: Prescribe to Available Pharmacies

If the patient's usual pharmacy is out of stock, send the prescription to a pharmacy you've confirmed has Tobramycin available. For ophthalmic Tobramycin, independent pharmacies often have better stock than chains. For inhaled Tobramycin, work with the patient's specialty pharmacy to confirm supply before prescribing.

Step 3: Consider Formulation Switches

Sometimes a different Tobramycin formulation is available when the prescribed one isn't:

• Ophthalmic: If drops are out, ointment may be in stock (and vice versa). Ointment can be particularly useful for nighttime use.
• Inhaled: If TOBI nebulization solution is unavailable, generic inhaled Tobramycin may be available. If the patient is on TOBI Podhaler, switching to nebulized Tobramycin is possible with patient education on nebulizer technique.
• Injectable: Different vial sizes (2 mL vs. 30 mL) may have different availability. Pharmacy can adjust preparation accordingly.

Step 4: Evaluate Therapeutic Alternatives

When Tobramycin itself is unavailable, consider these evidence-based alternatives:

For ocular infections:

• Gentamicin 0.3% ophthalmic — same class, similar coverage, widely available ($5–$15)
• Moxifloxacin 0.5% ophthalmic — broader Gram-positive coverage, BID-TID dosing ($15–$30 generic)
• Ciprofloxacin 0.3% ophthalmic — fluoroquinolone alternative, available and affordable

For systemic infections:

• Gentamicin — direct aminoglycoside substitute (slightly less Pseudomonas activity)
• Amikacin — broader aminoglycoside, preferred for resistant organisms
• Disease-specific alternatives based on culture and sensitivity data

For CF Pseudomonas suppression:

• Aztreonam lysine inhalation (Cayston) — established alternative, same 28-day on/off cycle pattern
• Colistimethate (colistin) inhalation — used in some CF protocols, particularly in Europe

For detailed alternative comparisons, see: Alternatives to Tobramycin.

Step 5: Address Financial Barriers

If cost — not supply — is the barrier, point patients toward these resources:

• Discount coupons: GoodRx or SingleCare can bring generic ophthalmic Tobramycin to $4–$10
• PODCARE+ Savings Card: Novartis copay assistance for TOBI Podhaler — up to $14,000/year for commercially insured patients
• Novartis Patient Assistance Foundation: Free TOBI products for qualifying uninsured/underinsured patients
• CFF Compass: Cystic Fibrosis Foundation resource for navigating insurance and financial challenges
• Generic substitution: Switching from brand TOBI to generic inhaled Tobramycin can reduce costs by 50–70%

More savings strategies: How to help patients save money on Tobramycin.

Workflow Tips for Your Practice

Integrating shortage management into your clinical workflow can reduce disruptions:

Proactive Refill Planning

For CF patients on inhaled Tobramycin, build refill reminders into your EHR — ideally one week before the next on-cycle begins. This gives the specialty pharmacy time to locate stock and ship.

Staff Training

Train your front desk and clinical staff to:

• Direct patients reporting fill problems to Medfinder
• Escalate to the prescriber if stock cannot be found after checking 2–3 alternative pharmacies
• Have a list of pre-approved alternative prescriptions ready (e.g., "if Tobramycin ophthalmic is unavailable, provider approves Gentamicin ophthalmic")

Pharmacy Relationship Building

Establish relationships with 1–2 independent pharmacies and at least one specialty pharmacy in your area. These contacts become invaluable during shortages, as they can provide advance notice of supply disruptions and prioritize your patients' orders.

Documentation

When switching to alternatives due to shortage, document the clinical rationale in the patient's chart. This supports insurance appeals if the alternative requires prior authorization and protects you in case of adverse outcomes.

Final Thoughts

Drug shortages are a persistent challenge in modern healthcare, and Tobramycin is no exception. But with the right systems in place — from availability tools like Medfinder to pre-identified alternatives and financial assistance pathways — you can minimize disruptions to patient care.

For the supply context behind these recommendations, see our provider briefing: Tobramycin shortage: What providers need to know in 2026.

And for patient-facing resources you can share: How to find Tobramycin in stock near you.